Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1

Status

Recruiting 12Terminated 4Completed 4Withdrawn 3Not yet recruiting 2Active not recruiting 2Unknown 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Hepatoblastoma 1Breast Neoplasms 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Tissue Banks × Clear all
NCT00298064 2023-07-05

Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer

University of New Mexico

Phase NA Withdrawn
Gynecologic

Uterine Cervical Neoplasms

NCT01302002 2016-02-23

The Use of Metformin in Early Breast Cancer Patients Pre-Surgery

Instituto Nacional de Cancer, Brazil

Phase EARLY_PHASE1 Withdrawn
Breast

Breast Neoplasms

NCT00228683 2013-11-26

Hepatoblastoma Biology Study and Tissue Bank

Emory University

Phase NA Withdrawn
Gastrointestinal

Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡